Metraipolis › archive › dc_1985f7a58654

CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice — Europe PMC PMID:41573517

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41573517
DOI
10.3389/fnmol.2025.1728279
License (as archived)
solo-consultazione
Archived
2026-11-07T00:04:17.913Z
SHA-256 of the archived text
f17ae9e6584ff3be3f16c105314776ecd359eaff4a4dc0d10f3e37220a197549
Stable URL of this page
https://metraipolis.com/documento/dc_1985f7a58654

How to cite

CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice — Europe PMC PMID:41573517 — Europe PMC (en), https://europepmc.org/article/MED/41573517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1985f7a58654 (Metraipolis archive dc_1985f7a58654, sha256 f17ae9e6584ff3be3f16c105314776ecd359eaff4a4dc0d10f3e37220a197549)
BibTeX
@misc{dc1985f7a58654,
  title = {CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice — Europe PMC PMID:41573517},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41573517},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1985f7a58654; sha256 f17ae9e6584ff3be3f16c105314776ecd359eaff4a4dc0d10f3e37220a197549},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41573517. Agents can read the archived copy with the MCP tool read_document.